The Ethical Principles Every Geneticist Needs to Know

(9)

Sponsored by the ACMG Ethics, Legal, and Social Issues Committee
ACMG designates credit of education in medical ethics and/or professional responsibility

Availability

No future session

Expires on 12/19/2024

Cost

$0.00

Credit Offered

1 CME (AMA) Credit

1 CME (Other) Credit

The Ethical Principles Every Geneticist Needs to Know
Sponsored by the ACMG Ethics, Legal, and Social Issues Committee

ACMG designates credit of education in medical ethics and/or professional responsibility
Tuesday, November 19, 2024 | 2:00pm-3:00pm ET

Description

This session aims to provide genetics professionals with an understanding of relevant ethical principles and considerations in patient care. An emphasis will be placed on ethical considerations in the clinic and diagnostic laboratory settings as demonstrated through case vignettes. Core ethical principles for discussion will be selected from the following list:

Privacy and confidentiality
Informed consent and juvenile assent
Beneficence and non- maleficence
Genetic discrimination and stigmatization
Justice and Equitable access to genomic technologies
Autonomy
Conflicts of Interest
Reproductive issues

Target Audience

Genetics Healthcare Providers (Medical Geneticists, Laboratory Geneticists, Genetic Counselors, Genetics Nurses)
Trainees in Medical Genetics (Fellows, Residents, Medical Students, Graduate Students)

Agenda

Presentation followed by live Q&A.

Topic	Presentation	Presenter
Welcome and Introduction		Tanya N. Eble, MS, CGC
Ethical Considerations in Genetic Testing for Critically Ill Minors: Navigating Consent, Assent, and Counseling	Bimal P. Chaudhari will address ethical issues that arise when counseling and obtaining consent for genetic testing in minors with a focus on the use of rapid genome sequencing in acutely and critically ill children. The “best interest” standard will be introduced, followed by discussion of the difference between informed consent and juvenile assent, the relationship of beneficence and non-maleficence to the best interests standard and finally the ways in which directive but non-coercive genetic counseling may best meet the best interest standard for the care of children.	Bimal P. Chaudhari, MD, MPH, FACMG
Navigating Ethical Boundaries: Privacy, Confidentiality, and Patient Autonomy in Family Healthcare Dynamics	Tanya N. Eble will address issues related to privacy and confidentiality as well as patient autonomy through the exploration of a scenario in which a mother and daughter are seen separately by the same provider. Protected health information will be defined, followed by a discussion of concepts of duty to warn, protection of patient privacy, and the right not to know.	Tanya N. Eble, MS, CGC
Ethical Challenges in the Era of Comprehensive Genetic Testing: Managing Unexpected Genetic Results in Cancer Treatment Decision-Making	S. Malia Fullerton will address ethical issues related to the identification of unexpected (secondary, and related) genetic results that may accompany results of comprehensive gene panels or other forms of genome-scale testing, using a case based in testing to inform cancer treatment. With pre-test genetic counseling increasingly unavailable in many specialist contexts, approaches to ensure adequate informed consent and, where appropriate, to manage follow-up of incidental findings, will be discussed.	Stephanie Malia Fullerton, DPhil

Learning Objectives
At the conclusion of this session, participants should be able to:
• Define the ethical concerns that might commonly be found in the context of clinical and laboratory genetics
• Identify select ethical principles in the context of clinical and laboratory genetics through exploration of case examples
• Identify resources for expanding knowledge of ethics in the clinical genetics setting

Tanya N. Eble, MS, CGC (Session Chair)

Associate Professor, Department of Molecular and Human Genetics

Baylor College of Medicine

Bimal P. Chaudhari, MD, MPH, FACMG

Assistant Professor of Pediatrics, Nationwide Children’s Hospital

Stephanie Malia Fullerton, DPhil

Professor Department of Bioethics & Humanities, University of Washington School of Medicine

Continuing Medical Education (CME AMA & CME Other)

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The American College of Medical Genetics and Genomics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

ACMG designates credit of education in medical ethics and/or professional responsibility

Claiming your Educational Credits

Complete the activity and carefully complete the evaluation form. The deadline to claim educational credits is within 30 days of the date of the activity. Educational credit requests after this date will not be accepted.

Learner Data Consent

ACMG Education reports learner data to respective agency boards and you will be asked for consent during the evaluation process. Your compliance with deadlines and completing evaluations are part of the process in meeting learner needs and ACMG’s education mission.

Accredited Continuing Education Financial Disclosure

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACMG Education Policies

Please review the policies below regarding the ACMG Education program

All of the relevant financial relationships listed for these individuals have been mitigated.

NAME	ROLE			RELATIONSHIP/ COMPANY
	Planning Member	Presenter Panelist Moderator	Peer Reviewer
Tanya N. Eble, MS, CGC	X	X		No Relevant Financial Relationships
Bimal P. Chaudhari, MD, MPH, FACMG		X		Grant : Inozyme Pharmaceuticals Inc.
Stephanie Malia Fullerton, DPhil		X		No Relevant Financial Relationships
Claudia Barnett	X			No Relevant Financial Relationships
Jane Radford	X			No Relevant Financial Relationships
Colleen Whelan	X		X	No Relevant Financial Relationships

Questions regarding CE credit should be directed to education@acmg.net